Kvantovaya Elektronika
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive
Impact factor
Submit a manuscript

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS



Kvantovaya Elektronika:
Year:
Volume:
Issue:
Page:
Find






Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register


Kvantovaya Elektronika, 2016, Volume 46, Number 6, Page 487 (Mi qe16411)  

Laser biophotonics

Laser biophotonics

A. N. Bashkatov, È. A. Genina, A. V. Priezzhev, V. V. Tuchin
Abstract: This issue of Quantum Electronics presents the papers that reflect the state-of-the-art of laser technologies used in biomedical studies and medical practice. Among the new technologies, one can note the methods of correlation and Doppler spectroscopy, as well as THz spectroscopy, in which biologically significant molecules are characterised by specific resonances. The latter topic is considered in the paper by Nazarov et al., where the dielectric function of aqueous solutions of glucose and albumin is studied using pulsed THz spectroscopy.
Received: 13.05.2016
English version:
Quantum Electronics, 2016, Volume 46, Issue 6, Pages 487
DOI: https://doi.org/10.1070/QEL16132
Bibliographic databases:
Document Type: Miscellaneous
Language: Russian


Citation: A. N. Bashkatov, È. A. Genina, A. V. Priezzhev, V. V. Tuchin, “Laser biophotonics”, Kvantovaya Elektronika, 46:6 (2016), 487 [Quantum Electron., 46:6 (2016), 487]
Linking options:
  • https://www.mathnet.ru/eng/qe16411
  • https://www.mathnet.ru/eng/qe/v46/i6/p487
  • Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    Квантовая электроника Quantum Electronics
    Statistics & downloads:
    Abstract page:262
    Full-text PDF :123
     
      Contact us:
     Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2024